Summary:
Portugal's Golden Visa program now includes a Cancer Research Golden Visa option for philanthropists.
Minimum investment of €750,000 qualifies donors for residency and cancer treatment coverage.
No pre-screening tests required, making it accessible for individuals with pre-existing conditions.
Contributions will significantly impact cancer research and treatment in Portugal.
Aims to attract socially conscious investors committed to improving the Portuguese healthcare landscape.
A New Era for Golden Visas in Portugal
BELMONTE, Portugal, Feb. 5, 2025 — In a significant policy shift, Portugal has discontinued its real estate investment option under the Golden Visa program as of late 2023. Now, philanthropists have the opportunity to invest in cancer research through the newly launched Cancer Research Golden Visa by Visadoro, a leading Portuguese investment migration firm.
Details of the Cancer Research Golden Visa
This innovative program enables philanthropic donors to contribute a minimum of €750,000 towards advanced cancer research projects in Portugal, qualifying them for the Golden Visa. This visa offers flexible residency, allowing holders to live in Portugal full-time without the obligation to do so, and paves the way for Permanent Residency (PR) and eventual citizenship with a minimal in-country presence of just 7 days per year during the 5-year Temporary Residency period.
Unmatched Benefits
Participants in this program will also benefit from free cutting-edge cancer treatment if diagnosed with cancer, extending coverage to their spouse and up to two dependents over 18, with additional financial contributions required for each dependent. Notably, there are no pre-screening tests required, making this program accessible to individuals with pre-existing conditions.
Societal Impact and Vision
This program aims to attract visionary philanthropists who are committed to making a socio-economic impact in Portugal, countering past criticisms of the Golden Visa program as being primarily beneficial to the real estate sector. By investing in cancer research, contributors will help accelerate the development of new treatments and technologies, ultimately benefiting patients in Portugal and beyond.
According to Jose Mineiro, founder and CEO of Visadoro, this initiative reflects their mission to leverage the Golden Visa program for the greater good of the Portuguese society. As global philanthropic giving towards cancer research reaches multi-billion dollar levels annually, the Cancer Research Golden Visa stands out as a valuable opportunity for those looking to make a difference.
For more information about the program, interested parties can visit www.ResearchGoldenVisa.com.
Comments
Join Our Community
Create an account to share your thoughts, engage with others, and be part of our growing community.